A person using adult stem cells in the provision of health care:

1. (1) must use adult stem cells that are properly manufactured and stored; and
2. (2) may only use adult stem cells in a clinical trial approved by the United States Food and Drug Administration.

Added by Acts 2015, 84th Leg., R.S., Ch. 992 (H.B. 177), Sec. 5, eff. September 1, 2015.